Moreover, through performing ROC analysis, we found that HOXC6, MMP9, SHOX2 and MYOD1 had a high diagnostic value (AUC>0.7) to distinguish primary and recurrent glioma tissues (Supplementary Figure S2). This evidence concerns the gene SHOX2 and central nervous system cancer.